Draft on Increasing Health Insurance Reimbursement Rates and Expanding Coverage
According to the Ministry of Health draft, health insurance reimbursements are planned to be gradually increased starting in 2027, with early cancer screenings and specialized treatments included in the coverage.
A new decree draft prepared by the Ministry of Health stipulates that the health insurance reimbursement rate for patients will be increased to 85% starting July 1, 2027, and reach 95% for certain groups in 2030.
Gradual Increase in Reimbursement Rates
According to the prepared decree draft, it is proposed that the reimbursement rate for medical examination and treatment costs for existing cases be increased from 80% to 85% starting July 1, 2027.
Within the scope of the roadmap for increasing these rates, it is planned to raise the reimbursement rate to 90% on July 1, 2029.
95% Support Rate for Specific Groups
According to the proposed regulations, starting July 1, 2030, the reimbursement rate for primary and basic health services will be increased to 95% for certain groups.
This high rate will benefit individuals aged 75 and over, those with mild disabilities, persons under 18, and members of households with average living standards.
Inclusion of Cancer and Hepatitis Screenings
It is envisaged that the health insurance fund will cover early diagnosis costs for seven common cancer types—namely uterine, breast, lung, prostate, colon, stomach, and liver—as well as for hepatitis B and C.
Additionally, hepatitis B and C tests are expected to be included in the insurance coverage as part of routine health checks starting July 1, 2027.
Pediatric Treatments and Chronic Disease Management
Within the scope of the draft, starting July 1, 2027, the costs of treatment for drug-resistant epilepsy in children, acute malnutrition in children under six, and nutritional therapy for premature infants will be covered.
Furthermore, starting January 1, 2028, payments will also begin for the costs of certain other preventive services related to the management of chronic diseases.